Product Description: JY-2 is a moderately selective and orally active Forkhead transcription factor forkhead box O1 (FoxO1) inhibitor that inhibits FoxO1 transcriptional activity with an IC50 of 22 μM. JY-2 shows moderate inhibition against FoxO3a and FoxO4. JY-2 shows anti-diabetic activity[1].
References: [1]Choi HE, et al. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model. Eur J Pharmacol. 2021 May 15;899:174011.
CAS Number: 339103-05-8
Molecular Weight: 292.12
Compound Purity: 99.75
Research Area: Metabolic Disease
Solubility: DMSO : 100 mg/mL (ultrasonic;warming;heat to 60°C)